Generic medicines are those where patent protection has expired and which may be produced by manufacturers other than the innovator company. The term ‘generic drug’ or ‘generic medicine’ is commonly understood, as defined by the World Health Organization (WHO), to mean a pharmaceutical product that is usually intended to be interchangeable with an innovator product, is manufactured without a license from the innovator company and is marketed after the expiry date of the patent or other exclusive rights. While the use of cheaper bioequivalent generic drugs over brand-name drugs has been widely discussed in literature, their market pricing and subsequent use is largely shaped by government policy-making as well as consumer and corporate decision-making. Problem faced may be by a Doctor or may be by Patient. This paper will discuss some of the issues around the generic drug in market.
Loading....